Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

63.2K
Overview
63.2K
Teratogenicity01:07

Teratogenicity

2.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

3.3K
The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.3K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

59.4K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
59.4K
Nondisjunction01:21

Nondisjunction

4.2K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive value of gB2 antibodies for maternal-fetal transmission after primary cytomegalovirus infection treated with valacyclovir.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Impact of a new image enhancement technology on the biometric measurements in pregnancy.

Archives of gynecology and obstetrics·2026
Same author

Safety of a cytomegalovirus-specific hyperimmunoglobulin in the prevention of maternal-fetal transmission after primary infection-results of an open-label, single-arm, prospective trial.

Archives of gynecology and obstetrics·2026
Same author

Update on: Firsttrimester Diagnosis and Therapy @ 11 - 13 <sup>+6</sup> weeks' gestation : Amendment to the Guideline of DEGUM, ÖGUM, SGUMGG, DGGG, ÖGG, Gynecologie Suisse, DGPM, DGPGM, BVF, ACHSE (AWMF S2e LL085-002 1.1.2024) (https://register.awmf.org/de/leitlinien/detail/085-002).

Geburtshilfe und Frauenheilkunde·2025
Same author

Update on: Firsttrimester Diagnosis and Therapy @ 11-13+6 weeks' gestation.

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2025
Same author

Counseling prior to cfDNA screening: are we giving the right numbers?

Archives of gynecology and obstetrics·2025
Same journal

Phototoxicity of brightfield live-cell imaging on murine ovarian follicles.

Archives of gynecology and obstetrics·2026
Same journal

First-trimester lipoprotein(a) and longitudinal renal biomarker trajectories preceding preeclampsia: a pilot cohort study.

Archives of gynecology and obstetrics·2026
Same journal

Correction: Intraoperative hemodynamics and anesthetic implications in superobese parturients undergoing cesarean delivery: a retrospective cohort analysis.

Archives of gynecology and obstetrics·2026
Same journal

Ophthalmic artery Doppler: reference values in low-risk pregnant women.

Archives of gynecology and obstetrics·2026
Same journal

Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study.

Archives of gynecology and obstetrics·2026
Same journal

One-year outcome after laser treatment of vulvar lichen sclerosus: a prospective observational trial.

Archives of gynecology and obstetrics·2026
See all related articles

Related Experiment Video

Updated: Sep 30, 2025

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

9.5K

Antenatal screening for chromosomal abnormalities.

Karl Oliver Kagan1, Jiri Sonek2, Peter Kozlowski3

  • 1Department of Obstetrics and Gynaecology, University of Tuebingen, Calwerstrasse 7, 72076, Tübingen, Germany. KOKagan@gmx.de.

Archives of Gynecology and Obstetrics
|March 13, 2022
PubMed
Summary
This summary is machine-generated.

Cell-free DNA (cfDNA) testing is the leading method for screening trisomy 21. Combining cfDNA with ultrasound offers optimal first-trimester screening for fetal chromosomal abnormalities and structural defects.

Keywords:
Cell-free fetal DNAFirst trimester screeningTrisomyUltrasound

More Related Videos

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
12:32

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

Published on: September 7, 2021

2.3K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

37.1K

Related Experiment Videos

Last Updated: Sep 30, 2025

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

9.5K
Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
12:32

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

Published on: September 7, 2021

2.3K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

37.1K

Area of Science:

  • Maternal-fetal medicine
  • Prenatal diagnostics
  • Genetics

Background:

  • Screening for chromosomal disorders has evolved significantly over 50 years.
  • Cell-free DNA (cfDNA) analysis is now the gold standard for trisomy 21 screening.
  • Current cfDNA screening primarily focuses on common trisomies, not all chromosomal disorders or structural anomalies.

Purpose of the Study:

  • To evaluate the optimal approach for first-trimester screening of fetal chromosomal disorders.
  • To highlight the limitations of cfDNA testing and the importance of integrated screening methods.

Main Methods:

  • Utilizing cell-free DNA (cfDNA) analysis for screening common trisomies.
  • Incorporating first-trimester ultrasound assessment, including nuchal translucency (NT) measurement.
  • Offering invasive diagnostic procedures like amniocentesis or chorionic villus sampling (CVS) when indicated.

Main Results:

  • cfDNA testing provides high accuracy for screening common trisomies like trisomy 21.
  • Integrated screening combining cfDNA and ultrasound improves detection rates for chromosomal and structural abnormalities.
  • Increased NT thickness or detected fetal defects warrant further invasive testing.

Conclusions:

  • The optimal first-trimester screening strategy involves a combination of cfDNA testing and ultrasound assessment.
  • Invasive diagnostic testing (amniocentesis or CVS) with chromosomal microarray is recommended for high-risk cases.
  • This integrated approach enhances the comprehensive evaluation of fetal health and chromosomal status.